Table 2 Injection frequency and drug type, needle practices, and outcomes among PWID, last 3 Mo. (N = 550)
Characteristic | N1 | N = 5502 |
|---|---|---|
Injections per month, n (%) | 549 | |
Less than once a month | 40 (7.3%) | |
Once a month | 35 (6.4%) | |
Once a week | 98 (17.9%) | |
Daily | 376 (68.5%) | |
Injections per day, n (%)3 | 375 | |
1 time3 | 43 (11.5%) | |
2–4 times3 | 239 (63.7%) | |
5–7 times3 | 69 (18.4%) | |
8 or more times3 | 24 (6.4%) | |
Drugs injected6 | ||
Methamphetamine, n (%) | 550 | 407 (74.0%) |
Heroin, n (%) | 550 | 308 (56.0%) |
Goofball (Methamphetamine + Heroin), n (%) | 550 | 122 (22.2%) |
Fentanyl, n (%) | 550 | 77 (14.0%) |
Speedball (Heroin + Cocaine), n (%) | 550 | 60 (10.9%) |
Opioids, other, n (%) | 550 | 36 (6.5%) |
Cocaine, n (%) | 550 | 35 (6.4%) |
Benzodiazepines, n (%) | 550 | 22 (4.0%) |
Steroids, n (%) | 550 | 13 (2.4%) |
Hormones, n (%) | 550 | 9 (1.6%) |
Amphetamines, other, n (%) | 550 | 8 (1.5%) |
Injection co-use, n (%) | 534 | |
Opioids & stimulants | 220 (41.2%) | |
Opioids only | 104 (19.5%) | |
Stimulants only | 210 (39.3%) | |
Discarded needles in puncture-proof containers, n (%) | 527 | |
Always/Most of the time | 320 (60.7%) | |
About half of the time | 62 (11.8%) | |
Rarely/Never | 145 (27.5%) | |
Injected with new, sterile needle, n (%) | 536 | |
Always/Most of the time | 334 (62.3%) | |
About half of the time | 146 (27.2%) | |
Rarely/Never | 56 (10.4%) | |
Injected with sterilized, used needle, n (%) | 531 | |
Always/Most of the time | 57 (10.7%) | |
About half of the time | 67 (12.6%) | |
Rarely/Never | 407 (76.6%) | |
Shared syringes to divide drugs, n (%) | 543 | 117 (21.5%) |
Shared needles, n (%) | 550 | 103 (18.7%) |
Shared others’ needles, n (%)4 | 102 | 65 (63.7%) |
Shared supplies, n (%) | 549 | 162 (29.5%) |
Shared others’ supplies, n (%)5 | 158 | 78 (49.4%) |
Reused needles, n (%) | 540 | 419 (77.6%) |
Reused supplies, n (%) | 541 | 359 (66.4%) |
Overdosed, n (%) | 550 | 57 (10.4%) |
HCV, past, n (%) | 550 | 82 (14.9%) |
HIV, past, n (%) | 550 | 35 (6.4%) |